Jolt Health Inc. Announces Share Consolidation Plan

Jolt Health Inc., a life sciences company based in Vancouver, has announced a consolidation of its common shares. Approved by shareholders and the Board of Directors, the ratio is set at 20 pre-consolidation shares to 1 post-consolidation share. Currently, there are 127,289,723 shares issued, which will be reduced to 6,364,486 once the consolidation takes effect.

The company will also consolidate its outstanding warrants and options on the same 20-to-1 basis. Each consolidated warrant and option will allow holders to acquire one share at a price multiplied by twenty.

This move aims to provide Jolt Health with increased flexibility in financing pursuits. The consolidation awaits approval from the Canadian Securities Exchange. The company's name will remain unchanged.